Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Investig

Department of Neurology, Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
The Journal of clinical investigation (Impact Factor: 13.22). 08/2012; 122(9):3063-87. DOI: 10.1172/JCI62636
Source: PubMed


Amyotrophic lateral sclerosis (ALS) is a progressive disease associated with neuronal cell death that is thought to involve aberrant immune responses. Here we investigated the role of innate immunity in a mouse model of ALS. We found that inflammatory monocytes were activated and that their progressive recruitment to the spinal cord, but not brain, correlated with neuronal loss. We also found a decrease in resident microglia in the spinal cord with disease progression. Prior to disease onset, splenic Ly6Chi monocytes expressed a polarized macrophage phenotype (M1 signature), which included increased levels of chemokine receptor CCR2. As disease onset neared, microglia expressed increased CCL2 and other chemotaxis-associated molecules, which led to the recruitment of monocytes to the CNS by spinal cord-derived microglia. Treatment with anti-Ly6C mAb modulated the Ly6Chi monocyte cytokine profile, reduced monocyte recruitment to the spinal cord, diminished neuronal loss, and extended survival. In humans with ALS, the analogous monocytes (CD14+CD16-) exhibited an ALS-specific microRNA inflammatory signature similar to that observed in the ALS mouse model, linking the animal model and the human disease. Thus, the profile of monocytes in ALS patients may serve as a biomarker for disease stage or progression. Our results suggest that recruitment of inflammatory monocytes plays an important role in disease progression and that modulation of these cells is a potential therapeutic approach.

Download full-text


Available from: Murugaiyan Gopal, Dec 23, 2013

Click to see the full-text of:

Article: Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Investig

6.5 MB

See full-text
    • "Thereby, miRNA expression profiles can reflect activation of specific pathogenic pathways. Dysregulation of miRNA expression has been reported, for example, in the SOD1-G93A mouse model of ALS or patient-derived tissue (Butovsky et al., 2012; Campos-Melo et al., 2013; De Felice et al., 2012; Toivonen et al., 2014). miRNAs are remarkably stable in serum and other body fluids as exosomal cargos or bound to specific proteins (Xu et al., 2012), and disease-related changes of extracellular miRNA abundance has been repeatedly shown. "
    [Show abstract] [Hide abstract]
    ABSTRACT: MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression and specific mircoRNA "fingerprints" are thought to contribute to and/or reflect certain disease conditions. Recently, we identified surprisingly homogeneous signatures of circulating miRNAs in the serum of familial amyotrophic lateral sclerosis (ALS) patients, which were already present in presymptomatic carriers of ALS gene mutations. Here, we characterize circulating miRNAs in the serum of sporadic ALS patients. We show that, in contrast to familial ALS, miRNA signatures of sporadic ALS are highly heterogeneous suggesting a number of different etiologies. Nevertheless, 2 miRNAs, miR-1234-3p and miR-1825, could be identified to be consistently downregulated in sporadic ALS. Bioinformatic analysis revealed miRNA fingerprints resembling those of familial ALS patients and mutation carriers in 61% of sporadic ALS patients, while the remaining subgroup had clearly different miRNA signatures. These data support a higher than expected contribution of genetic factors also to sporadic ALS. Moreover, our results indicate a more heterogeneous molecular etiology of sporadic ALS compared with (mono)genic cases, which should be considered for the development of disease modifying treatments. Copyright © 2015 Elsevier Inc. All rights reserved.
    Neurobiology of Aging 06/2015; 36(9). DOI:10.1016/j.neurobiolaging.2015.06.003 · 5.01 Impact Factor
  • Source
    • "To better understand the spectrum of phenotypes of reactive microglia, information on gene expression and insights into signaling pathways are necessary. Recently, the microglia transcriptome of SOD1 G93A mice, an amyotrophic lateral sclerosis (ALS) model was defined (Butovsky et al., 2012; Chiu et al., 2013). These microglia concurrently upregulate both neurotoxic and neuroprotective factors as well as genes associated with lysosomal activity and phagocytosis (Chiu et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The functional diversity and molecular adaptations of reactive microglia in the chronically inflamed central nervous system (CNS) are poorly understood. We previously showed that mice lacking multifunctional protein 2 (MFP2), a pivotal enzyme in peroxisomal b-oxidation, persistently accumulate reactive myeloid cells in the gray matter of the CNS. Here, we show that the increased numbers of myeloid cells solely derive from the proliferation of resident microglia and not from infiltrating monocytes. We defined the signature of Mfp2 2/2 microglia by gene expression profiling after acute isolation, which was validated by quantitative polymerase reaction (qPCR), immunohistochemical, and flow cytometric analysis. The features of Mfp2 2/2 microglia were compared with those from SOD1 G93A mice, an amyotrophic lateral sclerosis model. In contrast to the neurodegenerative milieu of SOD1 G93A spinal cord, neurons were intact in Mfp2 2/2 brain and Mfp2 2/2 microglia lacked signs of phagocytic and neurotoxic activity. The chronically reactive state of Mfp2 2/2 microglia was accompanied by the downregu-lation of markers that specify the unique microglial signature in homeostatic conditions. In contrast, mammalian target of rapamycin (mTOR) and downstream glycolytic and protein translation pathways were induced, indicative of metabolic adaptations. Mfp2 2/2 microglia were immunologically activated but not polarized to a pro-or anti-inflammatory phenotype. A peripheral lipopolysaccharide challenge provoked an exaggerated inflammatory response in Mfp2 2/2 brain, consistent with a primed state. Taken together, we demonstrate that chronic activation of resident microglia does not necessarily lead to phag-ocytosis nor overt neurotoxicity.
  • Source
    • "Proinflammatory, circulating monocytes infiltrate the DBA/2J ONH and have been observed in 10.5 month old animals (Howell et al., 2012). At young ages, our preliminary analysis suggests that microglia represent the majority of the CX3CR1-GFP+ cell-population contributing to early microgliosis within the ONH and central retina, since there are few cells that express the sialoadhesin (Siglec-1 or CD169) marker that labels peripheral monocytes, including macrophages or dendritic cells (Asano et al., 2011; Butovsky et al., 2012; Hartnell et al., 2001; O'Neill et al., 2013); although it is possible that sialoadhesin expression only identifies a subset of retinal/ONH peripheral monocytes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Microglia serve key homeostatic roles, and respond to neuronal perturbation and decline with high spatiotemporal resolution. The course of all chronic CNS pathologies is thus paralleled by local microgliosis and microglia activation beginning at early stages. However, the possibility of using live monitoring of microglia during early disease progression to predict the severity of neurodegeneration has not been unexplored. Since the retina allows live tracking of fluorescent microglia in their intact niche, here we investigated their early changes in relation to later optic nerve neurodegeneration. Thus, we used the DBA/2J mouse model of inherited glaucoma, which develops progressive retinal ganglion cell degeneration of variable severity during aging, and thus represents a useful model to study pathogenic mechanisms of retinal ganglion cell decline similar to human glaucoma. We imaged CX3CR1(+/GFP) microglial cells in vivo at ages ranging from 1 to 5 months by confocal scanning laser ophthalmoscopy (cSLO) and quantified cell density and morphological activation. We detected early microgliosis at the optic nerve head (ONH), where axonopathy first manifests, and could track attenuation of this microgliosis induced by minocycline. We also observed heterogeneous and dynamic patterns of early microglia activation in the retina. When the same animals were aged and analyzed for the severity of optic nerve pathology at 10 months of age, we found a strong correlation with the levels of ONH microgliosis at 3 to 4 months. Our findings indicate that live imaging and monitoring the time course and levels of early retinal microgliosis and microglia activation in glaucoma could serve as indicators of future neurodegeneration severity. © 2015. Published by The Company of Biologists Ltd.
    Disease Models and Mechanisms 03/2015; 8(5). DOI:10.1242/dmm.018788 · 4.97 Impact Factor
Show more